Health, Gilead, NASH, Liver, insitro, Google, VC, Venture Capital, Startup, Healthcare, Silicon Valley, Genetics, Genomics, Machine Learning, AI, Andreessen Horowitz, Jeff Bezos, BI Prime, Prime, GILD

A Jeff Bezos-backed startup just inked a deal with $84 billion biotech Gilead to make drugs for a troubling and increasingly common disease (GILD)

By

Neilson Barnard/Getty Images Pharmaceutical giant Gilead is teaming up with Silicon Valley startup Insitro to develop better drugs for a quietly emerging disease called NASH. Short for non-alcoholic steatohepatitis, NASH can lead to liver failure and is estimated to affect some 16 million Americans. Insitro is led by the former chief computing officer of Google […]

MustHaves.LA a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.